Carbon dot@MXene nanozymes with triple enzyme‐Mimic activities for mild NIR‐II photothermal‐Amplified nanocatalytic therapy
Bijiang Geng,Lang Yan,Yuping Zhu,Wenjing Shi,Haoneng Wang,Jingjing Mao,Lijun Ren,Jiqianzhu Zhang,Yijun Tian,Fangyuan Gao,Xiaofang Zhang,Jikuai Chen,Jiangbo Zhu
DOI: https://doi.org/10.1002/adhm.202202154
IF: 10
2022-11-11
Advanced Healthcare Materials
Abstract:Nanozymes have shown promising potential in disease treatment owing to the advantages of low‐cost, facile fabrication, and high stability. However, the highly complex tumor microenvironment (TME) and inherent low catalytic activity severely restrict the clinical applications of nanozymes. Herein, we construct a novel mild hyperthermia‐enhanced nanocatalytic therapy platform based on Z‐scheme heterojunction nanozymes by depositing N‐doped carbon dots (CDs) onto Nb2C nanosheets. CD@Nb2C nanozymes not only display outstanding photothermal effects in the safe and efficient NIR‐II window, but also possess triple enzyme‐mimic activities to obtain amplified ROS level. The triple enzyme‐mimic activities and NIR‐II photothermal properties of CD nanozymes are enhanced by the construction of Z‐scheme heterojunctions owing to the accelerate carrier transfer process. More importantly, the introduction of mild hyperthermia could further improve the peroxidase‐mimic and catalase‐mimic activities as well as GSH depletion abilities of CD@Nb2C nanozymes, thereby producing more ROS to efficient inhibit tumor growth. The combined therapy effect of CD@Nb2C nanozymes through mild NIR‐II photothermal‐enhanced nanocatalytic therapy could achieve complete tumor eradication. Our work highlights the efficient tumor therapy potential of heterojunction nanozymes. This article is protected by copyright. All rights reserved
nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials